NCT01179646View on ClinicalTrials.gov

Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2004

Study Completion Date

August 31, 2004

Conditions
Healthy
Interventions
DRUG

Pantoprazole 40 mg DR Tablet vs. Protonix 40 mg DR Tablet

Single dose crossover BE study

Trial Locations (1)

68502

MDS Pharma Services, Lincoln

Sponsors
All Listed Sponsors
lead

Kremers Urban Development Company

INDUSTRY

NCT01179646 - Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets | Biotech Hunter | Biotech Hunter